Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ariad Pharmaceuticals, Inc.    ARIA

Delayed Quote. Delayed  - 08/26 10:00:00 pm
10.25 USD   +0.49%
08/01 ARIAD PHARMACEU : PDL BioPharma Completes Second Tranche Payment Und..
07/28 ARIAD PHARMACEU : beats 2Q profit forecasts
07/28 ARIAD PHARMACEU : Reports Second Quarter and First Half 2016 Financi..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/22/2016 08/23/2016 08/24/2016 08/25/2016 08/26/2016 Date
10.56(c) 10.6(c) 10.02(c) 10.2(c) 10.25(c) Last
4 931 107 2 634 953 8 006 575 5 271 990 4 038 679 Volume
+2.42% +0.38% -5.47% +1.80% +0.49% Change
More quotes
Financials ($)
Sales 2016 191 M
EBIT 2016 -119 M
Net income 2016 -55,1 M
Debt 2016 230 M
Yield 2016 -
Sales 2017 239 M
EBIT 2017 -66,5 M
Net income 2017 -96,0 M
Debt 2017 276 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 11,6x
EV / Sales2017 9,44x
Capitalization 1 975 M
More Financials
Company
ARIAD Pharmaceuticals, Inc. operates as an oncology company which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer.Its products include Iclusig and Caregivers.The company was founded by Harvey J. Berger in April 1991 and is... 
More about the company
Surperformance© ratings of Ariad Pharmaceuticals, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARIAD PHARMACEUTICALS, INC
08/11 PDL BIOPHARMA : Completes Second Tranche Payment Under Royalty Transaction with ..
08/08 ARIAD PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
08/01 ARIAD PHARMACEUTICALS : PDL BioPharma Completes Second Tranche Payment Under Roy..
07/28 ARIAD PHARMACEUTICALS : beats 2Q profit forecasts
07/28 ARIAD PHARMACEUTICALS INC : Results of Operations and Financial Condition, Regul..
07/28 ARIAD PHARMACEUTICALS : Reports Second Quarter and First Half 2016 Financial Res..
07/22 ARIAD PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders,..
07/07 ARIAD PHARMACEUTICALS : Announces Webcast of Its Annual Stockholders Meeting
07/07 ARIAD PHARMACEUTICALS : Biotechnology Equities Under the Scanner - Exelixis, Nov..
07/05 ARIAD PHARMACEUTICALS : to Webcast Conference Call on Second Quarter 2016 Financ..
More news
Sector news : Bio Therapeutic Drugs
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/24DJAMGEN : FDA Rejects Amgen Hormonal-Imbalance Treatment
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/22DJPfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
08/23 Under New Structure, ARIAD Growth Opportunities May Be Undervalued
08/23 ARIAD Pharmaceuticals Could Be Benefiting From Prescriber Education
08/12 Ariad Is Worth A Look After Q2 Results
08/09 Market At All-Time Highs, September Can Be A Month Of Consolidation
07/29 BIOTECH FORUM DAILY DIGEST : Biotech Tries To Break Through Upward Resistance Le..
Advertisement
Chart ARIAD PHARMACEUTICALS, INC
Duration : Period :
Ariad Pharmaceuticals, Inc Technical Analysis Chart | ARIA | US04033A1007 | 4-Traders
Full-screen chart
Technical analysis trends ARIAD PHARMACEUTI...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 10,4 $
Spread / Average Target 1,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Paris Panayiotopoulos President, Chief Executive Officer & Director
Alexander John Denner Chairman
Manmeet Singh Soni Chief Financial Officer, Treasurer & Executive VP
Timothy P. Clackson Chief Scientific Officer
Frank G. Haluska Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARIAD PHARMACEUTICALS,..64.00%1 975
AMGEN, INC.5.94%128 696
GILEAD SCIENCES, INC.-21.17%105 269
CELGENE CORPORATION-9.16%84 325
REGENERON PHARMACEUTIC..-25.77%42 431
VERTEX PHARMACEUTICALS..-22.84%24 057
More Results